Videos in short-video sharing platforms as sources of information on heatstroke: a cross-sectional content analysis study. [PDF]
Liao Z +5 more
europepmc +1 more source
News-bulletin of the Council of Social Agencies, 1940-07
Indianapolis Council of Social Agencies
core
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Expert perspectives on the ecosystem of medical AI oversight in the GenAI era. [PDF]
Gilbert S, Dai T.
europepmc +1 more source
News-bulletin of the Council of Social Agencies, 1939-12
Indianapolis Council of Social Agencies
core
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
Misinformation Through the Lens of Dutch News Media and Public Health Authorities: Content Analysis of Topics and Narratives Present in Pandemic-Related Misinformation During COVID-19. [PDF]
Blanco-Herrero D +2 more
europepmc +1 more source
News-bulletin of the Council of Social Agencies, 1940-12
Indianapolis Council of Social Agencies
core
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto +12 more
wiley +1 more source
Reassessing the OX40/OX40L axis in atopic dermatitis after the termination of Rocatinlimab's clinical development program. [PDF]
Bieber T.
europepmc +1 more source

